FDA product code · Clinical Chemistry · Class 2

CGA: Glucose Oxidase, Glucose

CGA is FDA's product code for "Glucose Oxidase, Glucose": a Class 2 device classified under 21 CFR 862.1345, reviewed by the Clinical Chemistry panel.

510(k) review time for CGA

Across 15 510(k) clearances under CGA decided from 2018-01-01 to 2026-10-06, the median was 231 days from FDA receipt to decision. Half took between 100 and 375 days, and 80% were decided within 461 days. These are past clearances, not a forecast for a new submission.

Days from FDA receipt to 510(k) decision, CGA, decisions 2018-01-01 to 2026-10-06 (n = 15)
Fastest30
25th percentile100
Median231
75th percentile375
80th percentile461
90th percentile815
Slowest1,281

Source: openFDA 510(k) records, snapshot of 2026-10-06 (openFDA data as of 2026-09-28). Compare 510(k) review times across all device types, see every code side by side in the Clearance Timeline Estimator, or browse the clearances themselves in PredicateScope.

CGA in the public FDA record

Records naming CGA, from openFDA (snapshot of 2026-09-15)
510(k) clearances, all years401
Device recalls89
Establishment listings467
GUDID device identifiers1,084

Counts of records, not of devices or events. Adverse event reports for CGA are in MAUDEScope, as counts with the query shown: MAUDE has no denominator, so a report count is not a rate and does not show that a device caused an event.

FDA-recognized standards that cite CGA

5 FDA recognized consensus standards cite CGA, among them IEEE Std 11073-10417-2023; IEEE Std 11073-10417-2015; CLSI EP37 1st Edition. Horizontal standards such as biocompatibility, sterilization and software standards can apply without citing the code.

  • 13-148 IEEE Std 11073-10417-2023 — Health informatics - Device Interoperability Part 10417: Personal health device communication - Device Specialization - Glucose Meter
  • 13-90 IEEE Std 11073-10417-2015 — Health Informatics - Personal Health Device Communication Part 10417: Device Specialization - Glucose Meter
  • 7-284 CLSI EP37 1st Edition — Supplemental Tables for Interference Testing in Clinical Chemistry
  • 7-301 CLSI GP42 7th Edition — Collection of Capillary Blood Specimens
  • 7-348 CLSI EP37 2nd Edition — Supplemental Tables for Interference Testing in Clinical Chemistry

Source: FDA Recognized Consensus Standards, snapshot of 2026-09-01. Search them all in the Consensus Standards Lookup.

Related product codes